Rapid diagnosis and precision treatment of Helicobacter pylori infection in clinical settings
Authors:
- 24 June 2024
- journal article
- research article
- Published by Taylor & Francis in Critical Reviews in Microbiology
- Vol. 51 (2) , 369-398
Abstract
Helicobacter pylori is a gram-negative bacterium that colonizes the stomach of approximately half of the worldwide population, with higher prevalence in densely populated areas like Asia, the Caribbean, Latin America, and Africa. H. pylori infections range from asymptomatic cases to potentially fatal diseases, including peptic ulcers, chronic gastritis, and stomach adenocarcinoma. The management of these conditions has become more difficult due to the rising prevalence of drug-resistant H. pylori infections, which ultimately lead to gastric cancer and mucosa-associated lymphoid tissue (MALT) lymphoma. In 1994, the International Agency for Research on Cancer (IARC) categorized H. pylori as a Group I carcinogen, contributing to approximately 780,000 cancer cases annually. Antibiotic resistance against drugs used to treat H. pylori infections ranges between 15% and 50% worldwide, with Asian countries having exceptionally high rates. This review systematically examines the impacts of H. pylori infection, the increasing prevalence of antibiotic resistance, and the urgent need for accurate diagnosis and precision treatment. The present status of precision treatment strategies and prospective approaches for eradicating infections caused by antibiotic-resistant H. pylori will also be evaluated.Keywords
Funding Information
- National Natural Science Foundation of China (82372258)
- Guangdong Basic and Applied Basic Research Foundation (2022A1515220023)
- Research Foundation for Advanced Talents of Guandong Provincial People’s Hospital (KY012023293)
- Sanming Project of Medicine in Shenzen Municipality (SZSM201510050)
This publication has 243 references indexed in Scilit:
- Antibiotic resistance in Helicobacter pylori: From potential biomolecular mechanisms to clinical practiceJournal of Clinical Laboratory Analysis, 2023
- Helicobacter pylori infection, chronic atrophic gastritis and risk of stomach and esophagus cancer: Results from the prospective population‐based ESTHER cohort studyInternational Journal of Cancer, 2019
- Current and Future Treatment of Helicobacter pylori Infections2019
- Detection of the clarithromycin resistance of Helicobacter pylori in gastric mucosa by the amplification refractory mutation system combined with quantitative real‐time PCRCancer Medicine, 2019
- Armeniaspirol Antibiotic Biosynthesis: Chlorination and Oxidative Dechlorination Steps Affording Spiro[4.4]non‐8‐eneChemBioChem, 2018
- Sequential versus standard triple first-line therapy forHelicobacter pylorieradicationCochrane Database of Systematic Reviews, 2016
- In Silico Profiling of the Potentiality of Curcumin and Conventional Drugs for CagA Oncoprotein InactivationArchiv der Pharmazie, 2015
- Global burden of gastric cancer attributable toHelicobacterpyloriInternational Journal of Cancer, 2014
- Recovery of viable but non-culturable Campylobacter jejuni cells in two animal modelsFood Microbiology, 1999
- TheHelicobacter pylori genome: From sequence analysis to structural and functional predictionsProteins: Structure, Function, and Bioinformatics, 1999